Figure (Pro2h 0000 01)
Chemical structure diagram of propofol, showing a benzene ring with two isopropyl groups and one hydroxyl group attached.*
Propofol Injection, Emulsion
Product Images NDC 83634-603
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Propofol (NDC 83634-603). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Avenacy, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (Pro2h 0000 02)
A line graph depicting plasma propofol concentration (mg/mL) over time (minutes) after the end of infusion. It compares recovery profiles following 1-hour, 10-hour, and 10-day infusions, illustrating how plasma levels decline and relate to awakening time.*
Package Label – Principal Display Panel – Vial Label (Pro2h 0000 03)
Label for Propofol Injectable Emulsion, USP, 10 mg/mL strength, in a 20 mL vial containing 200 mg per vial. The label states it is for intravenous administration and single-patient use only. It includes directions to shake well before use, warnings about using aseptic technique, and sterilization details. The product is labeled by Avenacy, LLC.*
Package Label – Principal Display Panel – Vial Label (Pro2h 0000 04)
Propofol Injectable Emulsion USP, 10 mg/mL strength, presented as 500 mg per 50 mL in a 50 mL vial. The label indicates intravenous use with instructions to shake well before using and single-patient use only. The product is labeled by Avenacy, LLC and includes warnings about aseptic technique and components such as EDTA and natural rubber latex. Barcodes and lot/expiration date fields are visible.*
Package Label – Principal Display Panel – Vial Label (Pro2h 0000 05)
Label for Propofol Injectable Emulsion, USP, 10 mg/mL, containing 1,000 mg per 100 mL. It is for intravenous administration, supplied in a 100 mL vial, intended for single-patient use. The label includes a warning to shake well before using and notes that the emulsion is nonpyrogenic and does not contain natural rubber latex. It also provides storage instructions and manufacturer information for Avenacy, LLC.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
